Keyword: Johnson & Johnson
News
27.11.2012
- Merck KGaA said it would keep its non-prescription drugs unit even as a tussle over vitamin maker Schiff Nutrition highlighted the rich sale premium it could fetch. Merck's...
News
29.10.2012
- Global drugmakers are paying tens of millions of dollars to settle U.S. allegations that they bribed their way across emerging markets, but harsher penalties may be needed to deter...
News
16.10.2012
- Johnson & Johnson reported better-than-expected quarterly results on Tuesday, as pharmaceutical sales rebounded with the help of newer products, including treatments for prostate...
News
27.09.2012
- The European Union said it wants tougher rules governing the safety and monitoring of medical devices after weak EU regulations were partly blamed for a global scandal over French...
News
18.09.2012
- Johnson & Johnson is stepping a drive to tap into emerging healthcare technology by establishing new innovation centres in four of the world's biotech hot spots - California...
News
16.09.2012
- Johnson & Johnson said Sandra Peterson, currently a Bayer executive, will take on the new role of group worldwide chairman, overseeing a consent decree at the company's troubled...
News
13.08.2012
- Ireland's Elan is to spin off its Neotope drug discovery business platform as a separate public company, making Elan immediately profitable and potentially more appealing as a...
News
08.08.2012
- Dr. May Shana'a has been named group vice president, Technology and Growth Strategy, for Ashland Specialty Ingredients, a commercial unit of Ashland. The announcement was made by...
